請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/42351
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 林中梧(Chung-Wu Lin) | |
dc.contributor.author | Pei-Wen Wu | en |
dc.contributor.author | 吳佩玟 | zh_TW |
dc.date.accessioned | 2021-06-15T01:12:29Z | - |
dc.date.available | 2019-07-29 | |
dc.date.copyright | 2009-09-15 | |
dc.date.issued | 2009 | |
dc.date.submitted | 2009-07-30 | |
dc.identifier.citation | 1. Farag, S.S., and M.A. Caligiuri. 2006. Human natural killer cell development and biology. Blood Rev 20:123-137.
2. Cooper, M.A., T.A. Fehniger, S.C. Turner, K.S. Chen, B.A. Ghaheri, T. Ghayur, W.E. Carson, and M.A. Caligiuri. 2001. Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset. Blood 97:3146-3151. 3. Cooper, M.A., T.A. Fehniger, and M.A. Caligiuri. 2001. The biology of human natural killer-cell subsets. Trends Immunol 22:633-640. 4. Baume, D.M., M.J. Robertson, H. Levine, T.J. Manley, P.W. Schow, and J. Ritz. 1992. Differential responses to interleukin 2 define functionally distinct subsets of human natural killer cells. Eur J Immunol 22:1-6. 5. Caligiuri, M.A., A. Zmuidzinas, T.J. Manley, H. Levine, K.A. Smith, and J. Ritz. 1990. Functional consequences of interleukin 2 receptor expression on resting human lymphocytes. Identification of a novel natural killer cell subset with high affinity receptors. J Exp Med 171:1509-1526. 6. Cicuttini, F.M., and A.W. Boyd. 1994. Hemopoietic and lymphoid progenitor cells in human umbilical cord blood. Dev Immunol 4:1-11. 7. Gaddy, J., G. Risdon, and H.E. Broxmeyer. 1995. Cord blood natural killer cells are functionally and phenotypically immature but readily respond to interleukin-2 and interleukin-12. J Interferon Cytokine Res 15:527-536. 8. Ueno, Y., T. Miyawaki, H. Seki, A. Matsuda, K. Taga, H. Sato, and N. Taniguchi. 1985. Differential effects of recombinant human interferon-gamma and interleukin 2 on natural killer cell activity of peripheral blood in early human development. J Immunol 135:180-184. 9. O'Garra, A., and N. Arai. 2000. The molecular basis of T helper 1 and T helper 2 cell differentiation. Trends Cell Biol 10:542-550. 10. Di Santo, J.P. 2006. Natural killer cell developmental pathways: a question of balance. Annu Rev Immunol 24:257-286. 11. Szabo, S.J., S.T. Kim, G.L. Costa, X. Zhang, C.G. Fathman, and L.H. Glimcher. 2000. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100:655-669. 12. Szabo, S.J., B.M. Sullivan, C. Stemmann, A.R. Satoskar, B.P. Sleckman, and L.H. Glimcher. 2002. Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells. Science 295:338-342. 13. Zheng, W., and R.A. Flavell. 1997. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 89:587-596. 14. Zhou, M., and W. Ouyang. 2003. The function role of GATA-3 in Th1 and Th2 differentiation. Immunol Res 28:25-37. 15. Kimura, M.Y., and T. Nakayama. 2005. Differentiation of NK1 and NK2 cells. Crit Rev Immunol 25:361-374. 16. Perussia, B., and M.J. Loza. 2003. Linear '2-0-1' lymphocyte development: hypotheses on cellular bases for immunity. Trends Immunol 24:235-241. 17. Loza, M.J., and B. Perussia. 2001. Final steps of natural killer cell maturation: a model for type 1-type 2 differentiation? Nat Immunol 2:917-924. 18. Townsend, M.J., A.S. Weinmann, J.L. Matsuda, R. Salomon, P.J. Farnham, C.A. Biron, L. Gapin, and L.H. Glimcher. 2004. T-bet regulates the terminal maturation and homeostasis of NK and Valpha14i NKT cells. Immunity 20:477-494. 19. Glimcher, L.H. 2007. Trawling for treasure: tales of T-bet. Nat Immunol 8:448-450. 20. Naiche, L.A., Z. Harrelson, R.G. Kelly, and V.E. Papaioannou. 2005. T-box genes in vertebrate development. Annu Rev Genet 39:219-239. 21. Pearce, E.L., A.C. Mullen, G.A. Martins, C.M. Krawczyk, A.S. Hutchins, V.P. Zediak, M. Banica, C.B. DiCioccio, D.A. Gross, C.A. Mao, H. Shen, N. Cereb, S.Y. Yang, T. Lindsten, J. Rossant, C.A. Hunter, and S.L. Reiner. 2003. Control of effector CD8+ T cell function by the transcription factor Eomesodermin. Science 302:1041-1043. 22. Mullen, A.C., F.A. High, A.S. Hutchins, H.W. Lee, A.V. Villarino, D.M. Livingston, A.L. Kung, N. Cereb, T.P. Yao, S.Y. Yang, and S.L. Reiner. 2001. Role of T-bet in commitment of TH1 cells before IL-12-dependent selection. Science 292:1907-1910. 23. Lord, G.M., R.M. Rao, H. Choe, B.M. Sullivan, A.H. Lichtman, F.W. Luscinskas, and L.H. Glimcher. 2005. T-bet is required for optimal proinflammatory CD4+ T-cell trafficking. Blood 106:3432-3439. 24. Beima, K.M., M.M. Miazgowicz, M.D. Lewis, P.S. Yan, T.H. Huang, and A.S. Weinmann. 2006. T-bet binding to newly identified target gene promoters is cell type-independent but results in variable context-dependent functional effects. J Biol Chem 281:11992-12000. 25. Lee, D.U., O. Avni, L. Chen, and A. Rao. 2004. A distal enhancer in the interferon-gamma (IFN-gamma) locus revealed by genome sequence comparison. J Biol Chem 279:4802-4810. 26. Yang, Y., J.C. Ochando, J.S. Bromberg, and Y. Ding. 2007. Identification of a distant T-bet enhancer responsive to IL-12/Stat4 and IFNgamma/Stat1 signals. Blood 110:2494-2500. 27. Yu, J., M. Wei, Z. Boyd, E.B. Lehmann, R. Trotta, H. Mao, S. Liu, B. Becknell, M.S. Jaung, D. Jarjoura, G. Marcucci, L.C. Wu, and M.A. Caligiuri. 2007. Transcriptional control of human T-BET expression: the role of Sp1. Eur J Immunol 37:2549-2561. 28. Dybkaer, K., J. Iqbal, G. Zhou, H. Geng, L. Xiao, A. Schmitz, F. d'Amore, and W.C. Chan. 2007. Genome wide transcriptional analysis of resting and IL2 activated human natural killer cells: gene expression signatures indicative of novel molecular signaling pathways. BMC Genomics 8:230. 29. Fehniger, T.A., M.H. Shah, M.J. Turner, J.B. VanDeusen, S.P. Whitman, M.A. Cooper, K. Suzuki, M. Wechser, F. Goodsaid, and M.A. Caligiuri. 1999. Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response. J Immunol 162:4511-4520. 30. Yu, J., M. Wei, B. Becknell, R. Trotta, S. Liu, Z. Boyd, M.S. Jaung, B.W. Blaser, J. Sun, D.M. Benson, Jr., H. Mao, A. Yokohama, D. Bhatt, L. Shen, R. Davuluri, M. Weinstein, G. Marcucci, and M.A. Caligiuri. 2006. Pro- and antiinflammatory cytokine signaling: reciprocal antagonism regulates interferon-gamma production by human natural killer cells. Immunity 24:575-590. 31. Hatton, R.D., L.E. Harrington, R.J. Luther, T. Wakefield, K.M. Janowski, J.R. Oliver, R.L. Lallone, K.M. Murphy, and C.T. Weaver. 2006. A distal conserved sequence element controls Ifng gene expression by T cells and NK cells. Immunity 25:717-729. 32. Lewis, M.D., S.A. Miller, M.M. Miazgowicz, K.M. Beima, and A.S. Weinmann. 2007. T-bet's ability to regulate individual target genes requires the conserved T-box domain to recruit histone methyltransferase activity and a separate family member-specific transactivation domain. Mol Cell Biol 27:8510-8521. 33. Usui, T., J.C. Preiss, Y. Kanno, Z.J. Yao, J.H. Bream, J.J. O'Shea, and W. Strober. 2006. T-bet regulates Th1 responses through essential effects on GATA-3 function rather than on IFNG gene acetylation and transcription. J Exp Med 203:755-766. 34. Broxmeyer, H.E., G.W. Douglas, G. Hangoc, S. Cooper, J. Bard, D. English, M. Arny, L. Thomas, and E.A. Boyse. 1989. Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc Natl Acad Sci U S A 86:3828-3832. 35. Nitsche, A., M. Zhang, T. Clauss, W. Siegert, K. Brune, and A. Pahl. 2007. Cytokine profiles of cord and adult blood leukocytes: differences in expression are due to differences in expression and activation of transcription factors. BMC Immunol 8:18. 36. Khabar, K.S. 2007. Rapid transit in the immune cells: the role of mRNA turnover regulation. J Leukoc Biol 81:1335-1344. 37. Bakheet, T., B.R. Williams, and K.S. Khabar. 2006. ARED 3.0: the large and diverse AU-rich transcriptome. Nucleic Acids Res 34:D111-114. 38. Barreau, C., L. Paillard, and H.B. Osborne. 2005. AU-rich elements and associated factors: are there unifying principles? Nucleic Acids Res 33:7138-7150. 39. Marzi, S., A.G. Myasnikov, A. Serganov, C. Ehresmann, P. Romby, M. Yusupov, and B.P. Klaholz. 2007. Structured mRNAs regulate translation initiation by binding to the platform of the ribosome. Cell 130:1019-1031. 40. Willis, A.E. 1999. Translational control of growth factor and proto-oncogene expression. Int J Biochem Cell Biol 31:73-86. 41. Ben-Asouli, Y., Y. Banai, Y. Pel-Or, A. Shir, and R. Kaempfer. 2002. Human interferon-gamma mRNA autoregulates its translation through a pseudoknot that activates the interferon-inducible protein kinase PKR. Cell 108:221-232. 42. Khabar, K.S., and H.A. Young. 2007. Post-transcriptional control of the interferon system. Biochimie 89:761-769. 43. Theofilopoulos, A.N., S. Koundouris, D.H. Kono, and B.R. Lawson. 2001. The role of IFN-gamma in systemic lupus erythematosus: a challenge to the Th1/Th2 paradigm in autoimmunity. Arthritis Res 3:136-141. 44. Matsuda, J.L., T.C. George, J. Hagman, and L. Gapin. 2007. Temporal dissection of T-bet functions. J Immunol 178:3457-3465. 45. Wald, O., I.D. Weiss, H. Wald, H. Shoham, Y. Bar-Shavit, K. Beider, E. Galun, L. Weiss, L. Flaishon, I. Shachar, A. Nagler, B. Lu, C. Gerard, J.L. Gao, E. Mishani, J. Farber, and A. Peled. 2006. IFN-gamma acts on T cells to induce NK cell mobilization and accumulation in target organs. J Immunol 176:4716-4729. 46. Martin-Fontecha, A., L.L. Thomsen, S. Brett, C. Gerard, M. Lipp, A. Lanzavecchia, and F. Sallusto. 2004. Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming. Nat Immunol 5:1260-1265. 47. Kitamura, N., O. Kaminuma, A. Mori, T. Hashimoto, F. Kitamura, M. Miyagishi, K. Taira, and S. Miyatake. 2005. Correlation between mRNA expression of Th1/Th2 cytokines and their specific transcription factors in human helper T-cell clones. Immunol Cell Biol 83:536-541. 48. Rengarajan, J., S.J. Szabo, and L.H. Glimcher. 2000. Transcriptional regulation of Th1/Th2 polarization. Immunol Today 21:479-483. 49. Nishikomori, R., T. Usui, C.Y. Wu, A. Morinobu, J.J. O'Shea, and W. Strober. 2002. Activated STAT4 has an essential role in Th1 differentiation and proliferation that is independent of its role in the maintenance of IL-12R beta 2 chain expression and signaling. J Immunol 169:4388-4398. 50. Grenningloh, R., B.Y. Kang, and I.C. Ho. 2005. Ets-1, a functional cofactor of T-bet, is essential for Th1 inflammatory responses. J Exp Med 201:615-626. 51. Beima, K.M., M.M. Miazgowicz, M.D. Lewis, P.S. Yan, T.H. Huang, and A.S. Weinmann. 2006. T-bet binding to newly identified target gene promoters is cell type-independent but results in variable context-dependent functional effects. J Biol Chem 281:11992-12000. 52. Tada, M., and J.C. Smith. 2001. T-targets: clues to understanding the functions of T-box proteins. Dev Growth Differ 43:1-11. 53. Kispert, A., and B.G. Hermann. 1993. The Brachyury gene encodes a novel DNA binding protein. EMBO J 12:4898-4899. 54. Lord, G.M., R.M. Rao, H. Choe, B.M. Sullivan, A.H. Lichtman, F.W. Luscinskas, and L.H. Glimcher. 2005. T-bet is required for optimal proinflammatory CD4+ T-cell trafficking. Blood 106:3432-3439. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/42351 | - |
dc.description.abstract | 在免疫防禦系統中,CD4T (T helper cell, Th cell) 細胞、CD8T (T cytotoxic cell, Tc cell) 細胞以及自然殺手細胞 (Natural killer cell, NK cell) 扮演了重要的角色。入侵的病原體會刺激 CD4T 細胞使其活化並進一步分化為 Th1 及 Th2 兩種族群,各分泌不同的細胞激素,Th1細胞主要分泌 IL-2及IFN-r,而 Th2 細胞則分泌 IL-4及IL-13;近來在 CD8T 和 NK 也發現細胞有趨向 type I 及 type II 極化(polarization) 的現象。 T-bet,一種 T-box 家族的轉錄因子,藉著調控 IFN-r 基因的轉錄以促進細胞趨向 type I 的極化。T-bet 的調控機制先前已於NK淋巴癌細胞株YT (type 0-like T-betweak/IL-4+/IFN-r+) 與 NK92 (type I-like T-bet strong /IL-4-/IFN-r++)中被研究,結果顯示 YT 的 T-bet 表現較低是由於此基因在轉譯成蛋白質時有被抑制的現象,據此推論 T-bet 主要是受到後轉錄層面的調控。為了進ㄧ步探討人類 T 及 NK 細胞中 T-bet 的調控機制,我們自臍帶血中純化出 CD4T, CD8T 及 NK 細胞,利用細胞激素刺激細胞走向 type I 的分化路徑,再以 Flow cytometry 及 Real time PCR 分析這些 type I 極化後細胞其 T-bet 在蛋白質及 mRNA 上的表現程度,藉以研究此基因的調控機制。由於臍帶血 NK 細胞依據其CD56表現強弱而存在 CD56-, CD56dim 及 CD56bright 三種亞群,我們發現 NK 在刺激第0天到第5至第7天的 type I 分化前期中,CD56- 亞群比例將逐漸降低而 CD56bright 則逐漸增多。另外,CD56bright 亞群 T-bet 的 mRNA 表現量約為 CD56- 亞群的兩倍,蛋白質表現量卻也僅有5倍之差,推測 T-bet 於兩個亞群中不同的表現量是由於其在轉錄層面的調控機制;而在完全分化成 NK type I 細胞的第14天也發現 T-bet 蛋白質與 mRNA 表現量皆比尚未分化的第0天高出許多,顯示臍帶血中 type I 極化的 NK 細胞其 T-bet 於 type I 分化初期至第5~7天,亦或分化後期至完全 type I 極化的第14天皆是受到轉錄層面的調控;另一方面,T-bet 在 type I 極化的 CD4 T 細胞是受到轉錄層面的調控,而 CD8 T 細胞則較偏向後轉錄層面。最後,除了依傳統的方式以 IFN-r 及 T-bet 來分析細胞 type I 分化的程度,我們更確立了一些 type I 的細胞標記,例如可專一性作為臍帶血 NK type I 標記的 CD56,以及可作為 type I CD4 和CD8 T 細胞標記的 CD25 或 CXCR3。以上結果顯示,T-bet 於轉錄或後轉錄層面的調控在參與免疫系統中 T 及 NK 細胞的發育與成熟扮演了關鍵的角色。 | zh_TW |
dc.description.abstract | CD4T (T helper cell, Th cell), CD8T (T cytotoxic cell, Tc cell), and NK (natural killer) cells play important roles in immune defense system. When CD4T cells encounter invading organisms, they will be activated and differentiate into two functionally distinct subsets, Th1 and Th2, with different cytokine profiles. Th1 cells secrete interleukin 2 (IL-2) and interferon r(IFN-r), and Th2 cells secrete the cytokines interleukin 4 (IL-4) and interleukin 13 (IL-13). The phenomenon of type I vs type II polarization was recently found in CD8T cells and NK cells. T-bet, a member of the T-box transcription factor family, may promote type I polarization by regulating transcription of the IFN-r gene. Regulation of T-bet was studied in YT and NK92 lymphoma cell lines of NK-cell origin. YT cells had a type-0 IL-4+/IFN-r+/T-betweak profile, whereas NK92 cells had a type-I IL-4-/IFN-r++/T-betstrong profile. Our data indicated that weak expression of T-bet in the YT cells was due to a translational block in T-bet mRNA, suggesting T-bet regulation at post-transcriptional level. To further investigate T-bet regulation in human primary T and NK cells, we isolated umbilical cord blood (UCB) CD4T, CD8T and NK cells to study the protein and mRNA expression patterns of T-bet in cytokine stimulated type I-polarized cells by flow cytometry and real time PCR. It was reported that there were three distinct populations of human UCB NK cells based on the density of surface expression of CD56, which are CD56-, CD56dim and CD56bright subset, respectively. In the earlier stage of type I polarization, between the period of stimulation day 0 (D0) to day 5-7 (D5-7), the percentage of CD56- subset was decreased and CD56bright subset was increased. There was about 2-fold higher T-bet mRNA and only 5-fold higher expression of T-bet protein in CD56bright subset than in CD56- subset, suggesting different expression of T-bet among the two subsets was due to its transcriptional level regulation. When cells were at totally type I-polarized day 14 (D14), we found T-bet was transcriptional regulated either as both T-bet transcript and protein expression were much higher than day 0 (D0) naïve, undifferentiated NK cell. These data revealed transcriptional regulation of T-bet in UCB type I polarized NK cells from early stage of differentiation, day 0 (D0) to day 5-7 (D5-7) till day 14 (D14), when cell was totally type I polarized. Furthermore, we also showed transcriptional regulation of T-bet in type I polarized CD4T cells but post-transcriptional regulation in CD8T cells. Subsequently, in addition to analyze type I polarization based on IFN-r and T-bet expression traditionally, we also identified several type I surface markers, included CD56, specific for UCB type I polarized NK cells, and CD25 or CXCR3 for CD4T and CD8T cells. Taken together, these data showed T-bet regulation at transcriptional or post-transcriptional level is a critical event in the maturation of immune system and development of T and NK cells. | en |
dc.description.provenance | Made available in DSpace on 2021-06-15T01:12:29Z (GMT). No. of bitstreams: 1 ntu-98-R96444003-1.pdf: 2242114 bytes, checksum: ca4b437e1ebcfb3bd33570bda72724ce (MD5) Previous issue date: 2009 | en |
dc.description.tableofcontents | 口試委員會審定書............1
誌謝........................2 中文摘要....................4 Abstract....................5 Chapter 1: Introduction................7 Chapter 2: Materials and Methods.......11 Chapter 3: Results..........16 Discussion..................25 References..................29 Figures and Tables..........36 Appendix....................51 | |
dc.language.iso | en | |
dc.title | 探討 T-bet 於人類臍帶血第一型自然殺手細胞中的調控機制 | zh_TW |
dc.title | Regulation of T-bet Expression in Type I NK Cells from Human Umbilical Cord Blood | en |
dc.type | Thesis | |
dc.date.schoolyear | 97-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 林淑華(Shu-Wha Lin),李芳仁(Fang-Jen Lee),周綠蘋(Lu-Ping Chow) | |
dc.subject.keyword | type I 極化,後轉錄層面, | zh_TW |
dc.subject.keyword | type I polarization,post-transcriptional level,T-bet,IFN-r, | en |
dc.relation.page | 57 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2009-07-30 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 病理學研究所 | zh_TW |
顯示於系所單位: | 病理學科所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-98-1.pdf 目前未授權公開取用 | 2.19 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。